Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellular therapies trial design

Executive Summary

Early-phase clinical trial design for cellular therapies intended for cardiac diseases will be discussed by FDA's Biological Response Modifiers Advisory Committee March 18-19. The meeting will begin at 8:30 a.m. on both days at the Hilton in Silver Spring, Md.; the meeting's second day is scheduled to end at 3 p.m. [To sign up for a webcast of the meeting, visit FDAAdvisoryCommittee.com]...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS043019

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel